IDEXX Laboratories Inc
F:IX1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
IDEXX Laboratories Inc
F:IX1
|
US |
|
S
|
SSI Group Inc
XPHS:SSI
|
PH |
|
S
|
State Street Corp
SWB:ZYA
|
US |
IDEXX Laboratories Inc
IDEXX Laboratories makes diagnostic tools and software for veterinarians, animal clinics, farms, and water testing labs. Its core products help customers run blood, urine, fecal, and other tests on-site or in reference labs, so animal health problems can be found and treated faster. It also sells imaging and practice-management software that helps veterinary clinics manage records, appointments, and workflows. The company earns money mainly by selling instruments, test cartridges, consumables, and software subscriptions, then benefiting as customers keep buying replacement supplies and service support. Its biggest customer base is veterinary practices, but it also serves livestock and poultry producers and organizations that test drinking water. That mix gives IDEXX a recurring-revenue style business because many of its products are used over and over after the initial equipment sale. What makes IDEXX different is that it sits in the middle of animal health care rather than human health care. It is not just a device maker or just a software company; it combines lab diagnostics, in-clinic testing, and practice software in one business. That makes it an important supplier to veterinarians who want quicker answers, smoother clinic operations, and a steady source of test consumables and service support.
IDEXX Laboratories makes diagnostic tools and software for veterinarians, animal clinics, farms, and water testing labs. Its core products help customers run blood, urine, fecal, and other tests on-site or in reference labs, so animal health problems can be found and treated faster. It also sells imaging and practice-management software that helps veterinary clinics manage records, appointments, and workflows.
The company earns money mainly by selling instruments, test cartridges, consumables, and software subscriptions, then benefiting as customers keep buying replacement supplies and service support. Its biggest customer base is veterinary practices, but it also serves livestock and poultry producers and organizations that test drinking water. That mix gives IDEXX a recurring-revenue style business because many of its products are used over and over after the initial equipment sale.
What makes IDEXX different is that it sits in the middle of animal health care rather than human health care. It is not just a device maker or just a software company; it combines lab diagnostics, in-clinic testing, and practice software in one business. That makes it an important supplier to veterinarians who want quicker answers, smoother clinic operations, and a steady source of test consumables and service support.
Strong quarter: IDEXX said first-quarter revenue rose 14% as reported and 11% organically, led by Companion Animal Diagnostics and strong instrument placements.
Guidance raised: Full-year revenue, organic growth, operating margin, and EPS outlooks were all increased, with management citing stronger execution and a slightly better industry backdrop.
Visits still soft: U.S. same-store clinical visits fell about 1% in the quarter, and the company now expects full-year visits to decline 1.5%, with weakness concentrated in wellness visits.
Innovation working: InVue Dx, Catalyst menu additions, Cancer Dx, and software all contributed to growth, while the F&A rollout is progressing in a controlled launch and will broaden in Q2.
Capital returns: Free cash flow was strong at $234 million, and the company bought back $361 million of stock in the quarter.
Leadership change: Jay Mazelsky used the call as his final earnings call as CEO, with Mike Erickson set to take over leadership and emphasize diagnostics, software, and AI.
